Robert Janknegt

1.0k total citations
48 papers, 817 citations indexed

About

Robert Janknegt is a scholar working on Pharmacology, Infectious Diseases and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Robert Janknegt has authored 48 papers receiving a total of 817 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pharmacology, 9 papers in Infectious Diseases and 9 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Robert Janknegt's work include Antibiotics Pharmacokinetics and Efficacy (10 papers), Pneumonia and Respiratory Infections (7 papers) and Pharmaceutical studies and practices (5 papers). Robert Janknegt is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (10 papers), Pneumonia and Respiratory Infections (7 papers) and Pharmaceutical studies and practices (5 papers). Robert Janknegt collaborates with scholars based in Netherlands, United Kingdom and United States. Robert Janknegt's co-authors include Irma A. J. M. Bakker‐Woudenberg, Daan J.A. Crommelin, Siem de Marie, S. de Marie, J.W.M. van der Meer, Adri Steenhoek, I.M. Gould, E.E. Stobberingh, W. J. A. Wijnands and Hieronymus J. Derijks and has published in prestigious journals such as Journal of Antimicrobial Chemotherapy, Drugs and Clinical Pharmacokinetics.

In The Last Decade

Robert Janknegt

46 papers receiving 774 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert Janknegt Netherlands	13	248	223	168	96	95	48	817
Sumathi Nambiar United States	17	188 0.8×	241 1.1×	241 1.4×	133 1.4×	97 1.0×	37	911
G. Phillips United Kingdom	19	245 1.0×	308 1.4×	103 0.6×	68 0.7×	145 1.5×	49	1.0k
José Ramón Azanza Perea Spain	18	276 1.1×	277 1.2×	281 1.7×	59 0.6×	27 0.3×	108	1.2k
Pramodini Kale-Pradhan United States	20	242 1.0×	236 1.1×	167 1.0×	51 0.5×	34 0.4×	72	1.3k
Kunihiko Morita Japan	17	274 1.1×	134 0.6×	267 1.6×	47 0.5×	89 0.9×	78	843
Shu‐Wen Lin Taiwan	22	419 1.7×	274 1.2×	260 1.5×	71 0.7×	54 0.6×	76	1.1k
Thomas R. Beam United States	17	167 0.7×	401 1.8×	247 1.5×	57 0.6×	66 0.7×	45	869
Nicholas M. Moore United States	18	286 1.2×	264 1.2×	158 0.9×	56 0.6×	151 1.6×	54	1.2k
Raymond C. Bartlett United States	17	321 1.3×	297 1.3×	104 0.6×	103 1.1×	73 0.8×	57	942
Diamantis P. Kofteridis Greece	16	297 1.2×	262 1.2×	117 0.7×	41 0.4×	195 2.1×	60	1.0k

Countries citing papers authored by Robert Janknegt

Since Specialization

Citations

This map shows the geographic impact of Robert Janknegt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Janknegt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Janknegt more than expected).

Fields of papers citing papers by Robert Janknegt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Janknegt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Janknegt. The network helps show where Robert Janknegt may publish in the future.

Co-authorship network of co-authors of Robert Janknegt

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Janknegt. A scholar is included among the top collaborators of Robert Janknegt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Janknegt. Robert Janknegt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Scott, Mike, et al.. (2007). A prelude to the Matrix Models Supplement. Expert Opinion on Pharmacotherapy. 8(sup1). S1–S4. 4 indexed citations

Scott, Mike, et al.. (2007). Safe Therapeutic Economic Pharmaceutical Selection (STEPS): development, introduction and use in Northern Ireland. Expert Opinion on Pharmacotherapy. 8(sup1). S57–S63. 12 indexed citations

Janknegt, Robert. (2007). Triptans in the treatment of migraine: drug selection by means of the SOJA method. Expert Opinion on Pharmacotherapy. 8(sup1). S15–S30. 8 indexed citations

Scott, Mike, et al.. (2007). Matrix models and STEPS: concluding remarks. Expert Opinion on Pharmacotherapy. 8(sup1). S65–S67. 3 indexed citations

Janknegt, Robert, et al.. (2007). System of Objectified Judgement Analysis (SOJA) as a tool in rational and transparent drug-decision making. Expert Opinion on Pharmacotherapy. 8(sup1). S5–S14. 9 indexed citations

Janknegt, Robert. (2001). Using Health Outcomes Data to Inform Decision-Making. PharmacoEconomics. 19(Supplement 2). 49–52. 6 indexed citations

Janknegt, Robert. (1997). The treatment of staphylococcal infections with special reference to pharmacokinetic, pharmacodynamic and pharmacoeconomic considerations.. Pharmacy World & Science. 19(3). 133–141. 19 indexed citations

Janknegt, Robert & Adri Steenhoek. (1997). The System of Objectified Judgement Analysis (SOJA). Drugs. 53(4). 550–562. 38 indexed citations

Janknegt, Robert. (1996). Liposomal formulations of cytotoxic drugs. Supportive Care in Cancer. 4(4). 298–304. 22 indexed citations

10.

Janknegt, Robert, et al.. (1996). Hypnotics. PharmacoEconomics. 10(2). 152–163. 6 indexed citations

11.

Janknegt, Robert, W. J. A. Wijnands, & Ellen E. Stobberingh. (1994). Antibiotic policies in Dutch hospitals for the treatment of pneumonia. Journal of Antimicrobial Chemotherapy. 34(3). 431–442. 9 indexed citations

12.

Stobberingh, E.E., et al.. (1993). Antibiotic guidelines and antibiotic utilization in Dutch hospitals. Journal of Antimicrobial Chemotherapy. 32(1). 153–161. 19 indexed citations

13.

Janknegt, Robert, et al.. (1993). Antimicrobial drug use in hospitals in the Netherlands, Germany and Belgium. European Journal of Clinical Microbiology & Infectious Diseases. 12(11). 832–838. 35 indexed citations

14.

Janknegt, Robert. (1992). Future directions in antimicrobial chemotherapy. Pharmacy World & Science. 14(4). 229–244. 1 indexed citations

15.

Janknegt, Robert. (1991). Teicoplanin in perspective. Pharmacy World & Science. 13(4). 153–160. 11 indexed citations

16.

Hooymans, P. M., et al.. (1990). Comparison of clonazepam sorption to polyvinyl chloride-coated and polyethylene-coated tubings. Pharmacy World & Science. 12(5). 188–189. 3 indexed citations

17.

Janknegt, Robert. (1990). Aminoglycoside therapy. Pharmacy World & Science. 12(3). 81–90. 13 indexed citations

18.

Janknegt, Robert. (1990). Pharmacokinetics of antimicrobial agents in organ function impairment. Pharmacy World & Science. 12(4). 121–127.

19.

Janknegt, Robert. (1989). Fluoroquinolones. Pharmacy World & Science. 11(4). 124–127. 21 indexed citations

20.

Janknegt, Robert & Y. A. Hekster. (1989). Developments in quinolones. Pharmacy World & Science. 11(2). 33–43. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact